Teva Pharmaceutical Industries | Spese Di Vendita E Di Amministrazione


Selling And Administration Expenses Cambiamento
Abbvie ABBV:US $ 3.09B 254M
ALKERMES ALKS:US 145.78M 18.12M
Amgen AMGN:US $ 1.77B 427M
Antares Pharma ATRS:US $ 15.23M 783K
AstraZeneca AZN:LN 2.63B 357M
Biogen BIIB:US $ 806.2M 233.1M
Bristol Myers Squibb BMY:US $ 2.72B 1.01B
Eli Lilly And LLY:US $ 1.55B 15.2M
Emergent Biosolutions EBS:US $ 82.1M 6.6M
Flexion Therapeutics FLXN:US $ 27.31M 2.58M
Gilead Sciences GILD:US $ 1.73B 624M
GlaxoSmithKline GSK:LN 2.92B 447M
Henry Schein HSIC:US $ 674.13M 114.49M
JAZZ PHA JAZZ:US 247.17M 39.92M
Lannett LCI:US $ 13.73M 1.41M
Novartis NOVN:VX 3.91B 590M
Perrigo Ordinary Shares PRGO:US 280.9M 13.5M
Pfizer PFE:US $ 3.59B 716M
Phibro Animal Health PAHC:US $ 48.38M 56K
Revance Therapeutics RVNC:US $ 55.82M 7.64M
Sun Pharmaceuticals SUNP:IN 17.2B 151.6M
Takeda 4502:JP 216.26B 13.88B
Teva Pharmaceutical Industries TEVA:US 1.01B 157M
Xeris Pharmaceuticals Inc XERS:US $ 16.48M 1.16M
Zoetis ZTS:US $ 520M 96M



Teva Pharmaceutical Industries Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2021.